Hepatitis B Screening, Prophylaxis and Reactivation in the Era of Rituximab-based Chemotherapy

Hepatitis B reactivation is a well-described complication in patients with inactive chronic hepatitis B receiving chemotherapy. Screening for HBV and preemptive therapy are recommended. However, the rates of HBV screening, prophylaxis and reactivation during rituximab-containing chemotherapy are unk...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Méndez-Navarro, Jorge, Corey, Kathleen E., Zheng, Hui, Barlow, Lydia L., Jang, Jae Young, Lin, Wenyu, Zhao, Hong, Shao, Run-Xuan, McAfee, Steven L., Chung, Raymond T.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736143/
https://ncbi.nlm.nih.gov/pubmed/20738779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2010.02332.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg